生物活性 | |||
---|---|---|---|
描述 | PROTAC CDK9 Degrader-1 is a CRBN-recruiting PROTAC selectively targeting on CDK9, consist of a CDK9 ligand (aminopyrazole analog) linked to a CRBN E3 ligand thalidomide. Treatment with PROTAC CDK9 Degrader-1 led to a degradation of CDK9 by ~56% and ~65%, but not CDK2 or 5, at concentration of 10 and 20μM in HCT116 cells. Both of the phosphorylation status of Ser2 on RPB1, a direct substrate of CDK9, and the protein level of pro-survival protein Mcl-1 of which activity was regulated by CDK9, were decreased due to the degradation of CDK9 by addition of 10 or 20μM PROTAC CDK9 Degrader-1[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.63mL 0.33mL 0.16mL |
8.15mL 1.63mL 0.81mL |
16.30mL 3.26mL 1.63mL |
参考文献 |
---|